J 115814
Latest Information Update: 17 Dec 2003
Price :
$50 *
At a glance
- Originator Banyu
- Class Morpholines; Pyridines; Thiazoles
- Mechanism of Action Neuropeptide Y receptor antagonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- No development reported Obesity
Most Recent Events
- 17 Dec 2003 No development reported - Preclinical for Obesity in Japan (unspecified route)
- 14 Aug 2001 Preclinical development for Obesity in Japan (Unknown route)